Annual EBIT
-$10.16 M
-$7.71 M-315.72%
December 31, 2023
Summary
- As of February 12, 2025, ATXI annual earnings before interest & taxes is -$10.16 million, with the most recent change of -$7.71 million (-315.72%) on December 31, 2023.
- During the last 3 years, ATXI annual EBIT has fallen by -$4.94 million (-94.82%).
- ATXI annual EBIT is now -315.72% below its all-time high of -$2.44 million, reached on December 31, 2022.
Performance
ATXI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.09 M
-$386.00 K-14.29%
September 30, 2024
Summary
- As of February 12, 2025, ATXI quarterly earnings before interest & taxes is -$3.09 million, with the most recent change of -$386.00 thousand (-14.29%) on September 30, 2024.
- Over the past year, ATXI quarterly EBIT has dropped by -$3.70 million (-600.32%).
- ATXI quarterly EBIT is now -283.31% below its all-time high of $1.68 million, reached on December 31, 2022.
Performance
ATXI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$9.52 M
-$3.60 M-60.81%
September 30, 2024
Summary
- As of February 12, 2025, ATXI TTM earnings before interest & taxes is -$9.52 million, with the most recent change of -$3.60 million (-60.81%) on September 30, 2024.
- Over the past year, ATXI TTM EBIT has increased by +$636.00 thousand (+6.26%).
- ATXI TTM EBIT is now -924.76% below its all-time high of -$929.00 thousand, reached on March 31, 2016.
Performance
ATXI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ATXI EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -315.7% | -600.3% | +6.3% |
| 3 y3 years | -94.8% | -240.3% | -155.2% |
| 5 y5 years | +53.5% | -32.9% | +41.2% |
ATXI EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -315.7% | at low | -283.3% | +57.5% | -289.7% | +7.3% |
| 5 y | 5-year | -315.7% | +61.3% | -283.3% | +57.5% | -289.7% | +63.8% |
| alltime | all time | -315.7% | +61.3% | -283.3% | +72.8% | -924.8% | +63.8% |
Avenue Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.09 M(+14.3%) | -$9.52 M(+60.8%) |
| Jun 2024 | - | -$2.70 M(-37.9%) | -$5.92 M(-18.2%) |
| Mar 2024 | - | -$4.35 M(-804.9%) | -$7.24 M(-28.8%) |
| Dec 2023 | -$10.16 M(+315.7%) | $617.00 K(+20.3%) | -$10.16 M(+11.7%) |
| Sep 2023 | - | $513.00 K(-112.8%) | -$9.09 M(-11.4%) |
| Jun 2023 | - | -$4.02 M(-44.8%) | -$10.26 M(+49.8%) |
| Mar 2023 | - | -$7.27 M(-531.7%) | -$6.85 M(+180.5%) |
| Dec 2022 | -$2.44 M(-34.5%) | $1.68 M(-354.4%) | -$2.44 M(-51.5%) |
| Sep 2022 | - | -$662.00 K(+9.6%) | -$5.03 M(-4.0%) |
| Jun 2022 | - | -$604.00 K(-78.9%) | -$5.24 M(-6.2%) |
| Mar 2022 | - | -$2.86 M(+215.4%) | -$5.59 M(+49.9%) |
| Dec 2021 | -$3.73 M(-28.4%) | -$907.00 K(+4.0%) | -$3.73 M(-2.4%) |
| Sep 2021 | - | -$872.00 K(-8.3%) | -$3.82 M(-4.1%) |
| Jun 2021 | - | -$951.00 K(-5.0%) | -$3.99 M(-19.3%) |
| Mar 2021 | - | -$1.00 M(+0.2%) | -$4.94 M(-5.2%) |
| Dec 2020 | -$5.21 M | -$999.00 K(-3.7%) | -$5.21 M(-46.2%) |
| Sep 2020 | - | -$1.04 M(-45.5%) | -$9.69 M(-11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$1.90 M(+49.4%) | -$10.97 M(-32.2%) |
| Mar 2020 | - | -$1.27 M(-76.7%) | -$16.18 M(-38.4%) |
| Dec 2019 | -$26.27 M(+20.4%) | -$5.47 M(+135.6%) | -$26.27 M(+5.5%) |
| Sep 2019 | - | -$2.32 M(-67.3%) | -$24.89 M(-1.1%) |
| Jun 2019 | - | -$7.11 M(-37.4%) | -$25.18 M(+10.7%) |
| Mar 2019 | - | -$11.36 M(+176.9%) | -$22.75 M(+4.3%) |
| Dec 2018 | -$21.82 M(+83.6%) | -$4.10 M(+57.3%) | -$21.82 M(-8.9%) |
| Sep 2018 | - | -$2.61 M(-44.3%) | -$23.96 M(-1.0%) |
| Jun 2018 | - | -$4.68 M(-55.1%) | -$24.19 M(+11.0%) |
| Mar 2018 | - | -$10.43 M(+67.0%) | -$21.80 M(+83.5%) |
| Dec 2017 | -$11.88 M(+363.3%) | -$6.24 M(+119.7%) | -$11.88 M(+90.6%) |
| Sep 2017 | - | -$2.84 M(+23.9%) | -$6.24 M(+64.3%) |
| Jun 2017 | - | -$2.29 M(+354.1%) | -$3.80 M(+77.3%) |
| Mar 2017 | - | -$505.00 K(-15.3%) | -$2.14 M(-16.5%) |
| Dec 2016 | -$2.56 M | -$596.00 K(+48.3%) | -$2.56 M(+30.3%) |
| Sep 2016 | - | -$402.00 K(-37.0%) | -$1.97 M(+25.7%) |
| Jun 2016 | - | -$638.00 K(-31.3%) | -$1.57 M(+68.7%) |
| Mar 2016 | - | -$929.00 K | -$929.00 K |
FAQ
- What is Avenue Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Avenue Therapeutics?
- What is Avenue Therapeutics annual EBIT year-on-year change?
- What is Avenue Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly EBIT year-on-year change?
- What is Avenue Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Avenue Therapeutics?
- What is Avenue Therapeutics TTM EBIT year-on-year change?
What is Avenue Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ATXI is -$10.16 M
What is the all time high annual EBIT for Avenue Therapeutics?
Avenue Therapeutics all-time high annual earnings before interest & taxes is -$2.44 M
What is Avenue Therapeutics annual EBIT year-on-year change?
Over the past year, ATXI annual earnings before interest & taxes has changed by -$7.71 M (-315.72%)
What is Avenue Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ATXI is -$3.09 M
What is the all time high quarterly EBIT for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly earnings before interest & taxes is $1.68 M
What is Avenue Therapeutics quarterly EBIT year-on-year change?
Over the past year, ATXI quarterly earnings before interest & taxes has changed by -$3.70 M (-600.32%)
What is Avenue Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ATXI is -$9.52 M
What is the all time high TTM EBIT for Avenue Therapeutics?
Avenue Therapeutics all-time high TTM earnings before interest & taxes is -$929.00 K
What is Avenue Therapeutics TTM EBIT year-on-year change?
Over the past year, ATXI TTM earnings before interest & taxes has changed by +$636.00 K (+6.26%)